Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.24% | 28.39% | 25.54% | 22.46% | 14.43% |
| Total Depreciation and Amortization | -26.85% | -58.31% | -70.85% | -74.50% | -72.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -246.13% | -283.92% | -1,065.58% | -187.83% | -1.43% |
| Change in Net Operating Assets | 174.74% | -114.45% | -82.63% | -163.07% | -347.50% |
| Cash from Operations | 30.71% | 12.14% | 8.95% | 2.47% | -7.86% |
| Capital Expenditure | 99.72% | 99.72% | 31.99% | 56.45% | 53.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.72% | 99.72% | 31.99% | 56.45% | 53.95% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | 114.14% | 107.32% | -38,044.44% | -35,658.33% | -45,445.45% |
| Issuance of Common Stock | -68.13% | -71.84% | 68.34% | 658.71% | 645.18% |
| Repurchase of Common Stock | -- | -- | 73.33% | 99.32% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 74.83% | 79.44% | -0.63% | -344.11% | -325.88% |
| Cash from Financing | -64.14% | -69.52% | 95.01% | 845.43% | 810.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -493.84% | -222.22% | 111.04% | 126.48% | 108.27% |